ClinConnect ClinConnect Logo
Search / Trial NCT06485934

Kinesiophobia Scale for the Upper Extremity

Launched by EMRE ŞENOCAK · Jun 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Kinesiophobia Shoulder Development Of Scale

ClinConnect Summary

This clinical trial is focused on understanding kinesiophobia, which is the fear of movement that can affect people with shoulder injuries. Researchers want to create a new questionnaire specifically for people dealing with shoulder pain, as current questionnaires don’t address their needs. The goal is to better evaluate how this fear impacts their recovery and treatment.

To participate in the study, individuals aged 65 to 74 who have specific shoulder issues and score above 37 on an existing kinesiophobia test may be eligible. Participants will attend two meetings where they will answer questions about their experiences; the first meeting will take place soon after joining the study, and the second will happen within a week. It's important to note that individuals with certain conditions, such as cancer or those who have recently received physical therapy, cannot participate. This study aims to improve understanding of how fear of movement affects recovery from shoulder injuries, which could lead to better support and treatment options for patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Tampa Kinesiophobia Score \>37 points
  • Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity
  • Mini-Mental State Examination score \>24 points
  • Exclusion Criteria:
  • Malignancy,
  • Psychiatric drug use,
  • Use of painkillers during evaluation periods,
  • Those who received physiotherapy before the study (last 6 months),
  • Those whose education level is below secondary school level,

About Emre şenocak

Emre Şenocak is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Emre Şenocak collaborates with leading researchers and healthcare institutions to design and implement rigorous clinical studies. By prioritizing ethical standards, patient safety, and scientific integrity, the organization aims to accelerate the development of groundbreaking treatments across various therapeutic areas, ultimately contributing to the enhancement of global health.

Locations

İstanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Abdurrahman Tanhan, PhD

Study Chair

Bitlis Eren University

Zeynep Hoşbay, Associate Professor

Study Chair

Biruni University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported